| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corvus Pharmaceuticals, Inc. (CRVS) has 8 insiders with recent SEC Form 4 filings, including 20 buys and 0 sells. CRVS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.34M | $99.35M | - | |
| CEO | 1.00M | $11.91M | - | |
| Other | 400.0K | $4.76M | - | |
| CFO | 400.0K | $4.76M | - | |
| Other | 100.0K | $1.19M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2018 | Novo Holdings A/s58 | 10% Owner | Buy | 1,176,470 | $8.50 | $9,999,995.00 | +36.3% | |
| Mar 12, 2018 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 588,235 | $8.50 | $4,999,997.50 | +10.9% | |
| Mar 12, 2018 | Thompson Peter A.65 | Director, 10% Owner | Buy | 588,235 | $8.50 | $4,999,997.50 | +10.9% | |
| Mar 12, 2018 | Miller Richard A Md64 | President And CEO | Buy | 100,000 | $8.50 | $850,000.00 | +9.9% | |
| Mar 12, 2018 | Adams Street Partners LLC | 10% Owner | Buy | 588,235 | $8.50 | $4,999,997.50 | New | |
| Nov 20, 2017 | Miller Richard A Md64 | President And CEO | Buy | 10,000 | $10.79 | $107,850.00 | +1.0% | |
| Jun 23, 2017 | Novo Holdings A/s58 | 10% Owner | Buy | 20,000 | $10.95 | $219,000.00 | +0.6% | |
| Jun 13, 2017 | Miller Richard A Md64 | President And CEO | Buy | 25,000 | $9.88 | $247,083.62 | +0.5% | |
| Jun 24, 2016 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 1,000 | $12.98 | $12,983.00 | - | |
| Jun 24, 2016 | Thompson Peter A.65 | Director, 10% Owner | Buy | 1,000 | $12.98 | $12,983.00 | - |